Cargando…

Comparative Effectiveness of Rituximab and Common Induction Therapies for Lupus Nephritis: A Systematic Review and Network Meta-Analysis

OBJECTIVE: This study aimed to compare the efficacy and safety (infection events) between rituximab (RTX), tacrolimus (TAC), mycophenolate mofetil (MMF), and cyclophosphamide (CYC) as induction therapies in lupus nephritis (LN). METHODS: Electronic databases, including PubMed, EMBASE, and the Cochra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Kang, Yu, Yanqiu, Gao, Yuan, Zhao, Fei, Liang, Zheng, Gao, Junjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013779/ https://www.ncbi.nlm.nih.gov/pubmed/35444666 http://dx.doi.org/10.3389/fimmu.2022.859380

Ejemplares similares

Rituximab for treatment of severe lupus nephritis
por: Baskin, E, et al.
Publicado: (2008)

Clinical efficacy and safety of rituximab in lupus nephritis
por: Zhong, Zhiqing, et al.
Publicado: (2019)

Rituximab alone as induction therapy for membranous lupus nephritis: A multicenter retrospective study
por: Chavarot, Nathalie, et al.
Publicado: (2017)

Absolute quantification and characterization of oxylipins in lupus nephritis and systemic lupus erythematosus
por: He, Jingquan, et al.
Publicado: (2022)

Glomerular Expression of S100A8 in Lupus Nephritis: An Integrated Bioinformatics Analysis
por: Qijiao, Wei, et al.
Publicado: (2022)

Rituximab can Decrease Proteinuria in Refractory Lupus Nephritis
por: Suh, Chang-Hee
Publicado: (2022)

Efficacy and safety of immunosuppressive agents for adults with lupus nephritis: a systematic review and network meta-analysis
por: Jiang, Nan, et al.
Publicado: (2023)

Effectiveness and safety of common therapeutic drugs for refractory lupus nephritis: A network meta-analysis
por: Zhou, Jun, et al.
Publicado: (2020)

Belimumab in Lupus Nephritis: A Systematic Review and Meta-Analysis
por: Shrestha, Sanjeev, et al.
Publicado: (2021)

Dramatic Response of Lupus Enteritis, Nephritis, and Pancytopenia to Plasmapheresis and Rituximab
por: Aftab, Adan, et al.
Publicado: (2022)

Mesangial cell: A hub in lupus nephritis
por: Liu, Mengdi, et al.
Publicado: (2022)

Molecular mechanisms governing the progression of nephritis in lupus prone mice and human lupus patients
por: Daamen, Andrea R., et al.
Publicado: (2023)

Neuropsychiatric Lupus and Lupus Nephritis Successfully Treated with Combined IVIG and Rituximab: An Alternative to Standard of Care
por: Cheikh, Mohamed M., et al.
Publicado: (2022)

Lupus nephritis in children – 10 years’ experience
por: Szymanik-Grzelak, Hanna, et al.
Publicado: (2016)

Urinary exosome tsRNAs as novel markers for diagnosis and prediction of lupus nephritis
por: Chen, Shanshan, et al.
Publicado: (2023)

Predicting diagnostic gene expression profiles associated with immune infiltration in patients with lupus nephritis
por: Wang, Lin, et al.
Publicado: (2022)

Rituximab is effective in the treatment of nephritis in lupus patients, refractory to conventional immunosuppressive therapy
por: Martínez, R, et al.
Publicado: (2010)

Metabolic profiling reveals new serum signatures to discriminate lupus nephritis from systemic lupus erythematosus
por: Zhang, Yamei, et al.
Publicado: (2022)

Comparative efficacy and safety of mycophenolate mofetil and cyclophosphamide in the induction treatment of lupus nephritis: A systematic review and meta-analysis
por: Jiang, Yue-Peng, et al.
Publicado: (2020)

Semaphorin3A: A Potential Therapeutic Tool for Lupus Nephritis
por: Bejar, Jacob, et al.
Publicado: (2018)

Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus Nephritis
por: Gatto, Mariele, et al.
Publicado: (2019)

High-Throughput Sequencing-Based Analysis of T Cell Repertoire in Lupus Nephritis
por: Ye, Xiaolan, et al.
Publicado: (2020)

B Cell Subsets and Cellular Signatures and Disease Relapse in Lupus Nephritis
por: Yap, Desmond Y. H., et al.
Publicado: (2020)

CRAC Channel Controls the Differentiation of Pathogenic B Cells in Lupus Nephritis
por: Li, Xue, et al.
Publicado: (2021)

Discovery of Novel Circulating Immune Complexes in Lupus Nephritis Using Immunoproteomics
por: Tang, Chenling, et al.
Publicado: (2022)

IFN-I Mediates Lupus Nephritis From the Beginning to Renal Fibrosis
por: Ding, Xuewei, et al.
Publicado: (2021)

Immunomodulatory Activity of Mesenchymal Stem Cells in Lupus Nephritis: Advances and Applications
por: Li, Jicui, et al.
Publicado: (2022)

Systematic identification of key extracellular proteins as the potential biomarkers in lupus nephritis
por: Zhou, Xue, et al.
Publicado: (2022)

Treatment of refractory lupus nephritis using leflunomide: A prospective study
por: Zhang, Shuo, et al.
Publicado: (2023)

Anti-DFS70 Antibodies Are Associated With Proliferative Lupus Nephritis and Renal Pathological Activity
por: Chen, Dandan, et al.
Publicado: (2022)

Induction and Maintenance Treatment of Lupus Nephritis: A Comprehensive Review of Meta-Analyses
por: Shin, Jae Il, et al.
Publicado: (2022)

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis
por: Atisha‐Fregoso, Yemil, et al.
Publicado: (2020)

Efficacy and safety of Iguratimod as an add-on therapy for refractory lupus nephritis: A preliminary investigational study
por: Yan, Qingran, et al.
Publicado: (2023)

FKN Facilitates HK-2 Cell EMT and Tubulointerstitial Lesions via the Wnt/β-Catenin Pathway in a Murine Model of Lupus Nephritis
por: Fu, Dongdong, et al.
Publicado: (2019)

Early-Onset Neutropenia Induced by Rituximab in a Patient with Lupus Nephritis and Hemolytic Anemia
por: Arroyo-Ávila, Mariangelí, et al.
Publicado: (2015)

Mechanisms of Kidney Injury in Lupus Nephritis – the Role of Anti-dsDNA Antibodies
por: Yung, Susan, et al.
Publicado: (2015)

The Emerging Role of Renal Tubular Epithelial Cells in the Immunological Pathophysiology of Lupus Nephritis
por: Hong, Seokchan, et al.
Publicado: (2020)

The Spectrum of C4d Deposition in Renal Biopsies of Lupus Nephritis Patients
por: Ding, Ying, et al.
Publicado: (2021)

Exploring urine:serum fractional excretion ratios as potential biomarkers for lupus nephritis
por: Soliman, Samar A., et al.
Publicado: (2022)

Serological, fragmentomic, and epigenetic characteristics of cell-free DNA in patients with lupus nephritis
por: Wang, Fang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3rsb1bqt5vg5udc8af29laf6sl